Van ECK Associates Corp boosted its holdings in Amazon.com, Inc. (NASDAQ:AMZN – Get Rating) by 6.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,686,078 shares of the e-commerce giant’s stock after buying an additional 108,024 shares during the quarter. Van ECK Associates Corp’s holdings in Amazon.com were worth $190,527,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of AMZN. Bridgefront Capital LLC acquired a new position in Amazon.com in the first quarter valued at $228,000. Krane Funds Advisors LLC boosted its stake in Amazon.com by 239.1% in the first quarter. Krane Funds Advisors LLC now owns 78 shares of the e-commerce giant’s stock valued at $254,000 after acquiring an additional 55 shares in the last quarter. Range Financial Group LLC acquired a new position in Amazon.com in the first quarter valued at $258,000. My Personal CFO LLC acquired a new position in Amazon.com in the first quarter valued at $261,000. Finally, Worth Asset Management LLC acquired a new stake in shares of Amazon.com during the first quarter worth about $191,000. Hedge funds and other institutional investors own 57.64% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the stock. Oppenheimer decreased their target price on shares of Amazon.com from $165.00 to $130.00 and set an “outperform” rating for the company in a research note on Friday, October 28th. Citigroup decreased their target price on shares of Amazon.com from $185.00 to $145.00 and set a “buy” rating for the company in a research note on Friday, October 28th. Erste Group Bank downgraded shares of Amazon.com from a “buy” rating to a “hold” rating in a research note on Friday, November 18th. Mizuho decreased their target price on shares of Amazon.com from $155.00 to $135.00 and set a “buy” rating for the company in a research note on Friday, October 28th. Finally, Bank of America decreased their target price on shares of Amazon.com from $157.00 to $137.00 and set a “buy” rating for the company in a research note on Friday, October 28th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and forty-two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $145.56.
Insiders Place Their Bets
Amazon.com Trading Down 1.2 %
Shares of AMZN opened at $96.32 on Wednesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.94 and a quick ratio of 0.68. The firm has a 50 day simple moving average of $90.65 and a 200-day simple moving average of $109.96. Amazon.com, Inc. has a 1-year low of $81.43 and a 1-year high of $170.83. The stock has a market cap of $982.62 billion, a price-to-earnings ratio of 88.41, a price-to-earnings-growth ratio of 3.06 and a beta of 1.22.
Amazon.com (NASDAQ:AMZN – Get Rating) last released its earnings results on Thursday, October 27th. The e-commerce giant reported $0.20 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.02). The firm had revenue of $127.10 billion during the quarter, compared to analysts’ expectations of $127.47 billion. Amazon.com had a return on equity of 14.44% and a net margin of 2.25%. The firm’s revenue was up 14.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.31 earnings per share. Equities analysts forecast that Amazon.com, Inc. will post 0.68 EPS for the current fiscal year.
Amazon.com, Inc is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following business segments: North America, International, and Amazon Web Services (AWS). The North America segment includes retail sales of consumer products and subscriptions through North American-focused websites such as www.amazon.com and www.amazon.ca.
- Get a free copy of the StockNews.com research report on Amazon.com (AMZN)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- Is It Time To Get Aggressive With Defense Stocks?
Receive News & Ratings for Amazon.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amazon.com and related companies with MarketBeat.com's FREE daily email newsletter.